米索前列醇/来曲唑与米索前列醇/安慰剂对药物流产成功率的影响:一项随机临床试验

Q3 Medicine
Seyedeh Azam Pourhoseini, S. Niroumand, A. Akbari, Masoumeh Mirteimouri, F. Akhlaghi, Nayyereh Taheri, Neda Davaryari
{"title":"米索前列醇/来曲唑与米索前列醇/安慰剂对药物流产成功率的影响:一项随机临床试验","authors":"Seyedeh Azam Pourhoseini, S. Niroumand, A. Akbari, Masoumeh Mirteimouri, F. Akhlaghi, Nayyereh Taheri, Neda Davaryari","doi":"10.5812/semj-131460","DOIUrl":null,"url":null,"abstract":"Background: Abortion is the medical or surgical termination of pregnancy before the 20th week. However, dilation and curettage have been associated with hazards such as uterine rupture, heavy bleeding, and infection. Therefore, in recent decades, pharmacological therapies have become more widely accepted. Objectives: This research compared the medical abortion success rates of misoprostol/letrozole versus misoprostol/placebo. Methods: This randomized clinical study was conducted at Mashhad University of Medical Sciences hospitals between 2018 and 2019, involving pregnant women who were candidates for medical abortion. The study population was divided into two groups based on whether they had undergone cesarean section (CS). Each group was randomly assigned to either a control or an intervention group. In the CS group, there were 52 patients in the intervention group and 52 in the control group. The control group received a regimen of misoprostol and placebo, while the intervention group received a combination of misoprostol and letrozole. Results: There was no statistically significant difference in age (31.59 ± 5.6 vs. 31.06 ± 4.6, P value = 0.605), gestational age by ultrasound (11.20 ± 3.3 vs. 10.29 ± 2.6, P value = 0.135), or blood pressure between the control and intervention groups. However, the analysis showed a statistically significant difference in the rate of complete abortion (12 (23.5%) vs. 28 (54.9%), P value = 0.001) between the two groups. In the non-CS group, there was a significant difference in age between the control and intervention groups. The study analyses also revealed a significant difference in the rate of complete abortion between the two groups (24 (46.2%) vs. 36 (72.0%), P value = 0.008). Conclusions: Letrozole is recommended in combination with misoprostol for medical abortions because it increases the likelihood of complete abortion and reduces the duration of the abortion process.","PeriodicalId":39157,"journal":{"name":"Shiraz E Medical Journal","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparing the Effects of Misoprostol/Letrozole and Misoprostol/Placebo on Medical Abortion Success Rate: A Randomized Clinical Trial\",\"authors\":\"Seyedeh Azam Pourhoseini, S. Niroumand, A. Akbari, Masoumeh Mirteimouri, F. Akhlaghi, Nayyereh Taheri, Neda Davaryari\",\"doi\":\"10.5812/semj-131460\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Abortion is the medical or surgical termination of pregnancy before the 20th week. However, dilation and curettage have been associated with hazards such as uterine rupture, heavy bleeding, and infection. Therefore, in recent decades, pharmacological therapies have become more widely accepted. Objectives: This research compared the medical abortion success rates of misoprostol/letrozole versus misoprostol/placebo. Methods: This randomized clinical study was conducted at Mashhad University of Medical Sciences hospitals between 2018 and 2019, involving pregnant women who were candidates for medical abortion. The study population was divided into two groups based on whether they had undergone cesarean section (CS). Each group was randomly assigned to either a control or an intervention group. In the CS group, there were 52 patients in the intervention group and 52 in the control group. The control group received a regimen of misoprostol and placebo, while the intervention group received a combination of misoprostol and letrozole. Results: There was no statistically significant difference in age (31.59 ± 5.6 vs. 31.06 ± 4.6, P value = 0.605), gestational age by ultrasound (11.20 ± 3.3 vs. 10.29 ± 2.6, P value = 0.135), or blood pressure between the control and intervention groups. However, the analysis showed a statistically significant difference in the rate of complete abortion (12 (23.5%) vs. 28 (54.9%), P value = 0.001) between the two groups. In the non-CS group, there was a significant difference in age between the control and intervention groups. The study analyses also revealed a significant difference in the rate of complete abortion between the two groups (24 (46.2%) vs. 36 (72.0%), P value = 0.008). Conclusions: Letrozole is recommended in combination with misoprostol for medical abortions because it increases the likelihood of complete abortion and reduces the duration of the abortion process.\",\"PeriodicalId\":39157,\"journal\":{\"name\":\"Shiraz E Medical Journal\",\"volume\":\"38 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Shiraz E Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5812/semj-131460\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shiraz E Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/semj-131460","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景:流产是指在20周之前通过药物或手术终止妊娠。然而,宫内扩张和刮宫术与子宫破裂、大出血和感染等危险有关。因此,近几十年来,药物治疗已被广泛接受。目的:比较米索前列醇/来曲唑与米索前列醇/安慰剂的药物流产成功率。方法:本随机临床研究于2018 - 2019年在马什哈德医科大学附属医院进行,涉及拟进行药物流产的孕妇。研究人群根据是否接受过剖宫产(CS)分为两组。每组被随机分配到对照组或干预组。CS组干预组52例,对照组52例。对照组给予米索前列醇加安慰剂的治疗方案,干预组给予米索前列醇加来曲唑的治疗方案。结果:对照组与干预组在年龄(31.59±5.6比31.06±4.6,P值= 0.605)、超声胎龄(11.20±3.3比10.29±2.6,P值= 0.135)、血压方面差异均无统计学意义。然而,分析显示两组完全流产率差异有统计学意义(12例(23.5%)vs 28例(54.9%),P值= 0.001)。在非cs组中,对照组和干预组在年龄上有显著差异。研究分析还显示两组完全流产率有显著差异(24例(46.2%)vs 36例(72.0%),P值= 0.008)。结论:来曲唑与米索前列醇合用可增加完全流产的可能性,缩短流产时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparing the Effects of Misoprostol/Letrozole and Misoprostol/Placebo on Medical Abortion Success Rate: A Randomized Clinical Trial
Background: Abortion is the medical or surgical termination of pregnancy before the 20th week. However, dilation and curettage have been associated with hazards such as uterine rupture, heavy bleeding, and infection. Therefore, in recent decades, pharmacological therapies have become more widely accepted. Objectives: This research compared the medical abortion success rates of misoprostol/letrozole versus misoprostol/placebo. Methods: This randomized clinical study was conducted at Mashhad University of Medical Sciences hospitals between 2018 and 2019, involving pregnant women who were candidates for medical abortion. The study population was divided into two groups based on whether they had undergone cesarean section (CS). Each group was randomly assigned to either a control or an intervention group. In the CS group, there were 52 patients in the intervention group and 52 in the control group. The control group received a regimen of misoprostol and placebo, while the intervention group received a combination of misoprostol and letrozole. Results: There was no statistically significant difference in age (31.59 ± 5.6 vs. 31.06 ± 4.6, P value = 0.605), gestational age by ultrasound (11.20 ± 3.3 vs. 10.29 ± 2.6, P value = 0.135), or blood pressure between the control and intervention groups. However, the analysis showed a statistically significant difference in the rate of complete abortion (12 (23.5%) vs. 28 (54.9%), P value = 0.001) between the two groups. In the non-CS group, there was a significant difference in age between the control and intervention groups. The study analyses also revealed a significant difference in the rate of complete abortion between the two groups (24 (46.2%) vs. 36 (72.0%), P value = 0.008). Conclusions: Letrozole is recommended in combination with misoprostol for medical abortions because it increases the likelihood of complete abortion and reduces the duration of the abortion process.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Shiraz E Medical Journal
Shiraz E Medical Journal Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
63
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信